CASI Pharma (CASI) Misses Q4 EPS by 2c

CASI Pharma (NASDAQ: CASI) reported Q4 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03).

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Aspire Biopharma to acquire automotive supplier for $30 million
• Nvidia pitches Vera CPU to Chinese clients with August delivery target